These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21072832)

  • 1. Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma.
    Hobbie WL; Mostoufi SM; Carlson CA; Gruccio D; Ginsberg JP
    Pediatr Blood Cancer; 2011 Mar; 56(3):474-6. PubMed ID: 21072832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
    Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
    Villablanca JG; Khan AA; Avramis VI; Seeger RC; Matthay KK; Ramsay NK; Reynolds CP
    J Clin Oncol; 1995 Apr; 13(4):894-901. PubMed ID: 7707116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma.
    Marabelle A; Sapin V; Rousseau R; Periquet B; Demeocq F; Kanold J
    Pediatr Blood Cancer; 2009 Feb; 52(2):280-3. PubMed ID: 18839433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
    Villablanca JG; Khan AA; Avramis VI; Reynolds CP
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):410-5. PubMed ID: 8214363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
    Park JR; Villablanca JG; London WB; Gerbing RB; Haas-Kogan D; Adkins ES; Attiyeh EF; Maris JM; Seeger RC; Reynolds CP; Matthay KK;
    Pediatr Blood Cancer; 2009 Jan; 52(1):44-50. PubMed ID: 18937318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of growth failure caused by 13-CIS-retinoic acid administration after bone marrow transplantation for neuroblasoma.
    Inamo Y; Suzuki T; Mugishima H
    Endocr J; 1999 Mar; 46 Suppl():S113-5. PubMed ID: 12054112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
    Khan AA; Villablanca JG; Reynolds CP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):34-41. PubMed ID: 8995497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone function and treatment following bone marrow transplant for neuroblastoma.
    Olshan JS; Willi SM; Gruccio D; Moshang T
    Bone Marrow Transplant; 1993 Oct; 12(4):381-5. PubMed ID: 8275038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
    Kohler JA; Imeson J; Ellershaw C; Lie SO
    Br J Cancer; 2000 Nov; 83(9):1124-7. PubMed ID: 11027423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma.
    Chen SC; Murphy D; Sastry J; Shaikh MG
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):477-81. PubMed ID: 26056798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth failure in children after total body irradiation preparative for bone marrow transplantation.
    Hovi L; Saarinen UM; Siimes MA
    Bone Marrow Transplant; 1991; 8 Suppl 1():10-3. PubMed ID: 1760625
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating growth failure with diffusion tensor imaging in pediatric survivors of high-risk neuroblastoma treated with high-dose cis-retinoic acid.
    Delgado J; Jaramillo D; Chauvin NA; Guo M; Stratton MS; Sweeney HE; Barrera CA; Mostoufi-Moab S
    Pediatr Radiol; 2019 Jul; 49(8):1056-1065. PubMed ID: 31055614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma.
    Degar BA; Harrington RD; Rappeport JM; Woolfrey AE
    Med Pediatr Oncol; 1999 Apr; 32(4):308-10. PubMed ID: 10102029
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
    Flandin I; Hartmann O; Michon J; Pinkerton R; Coze C; Stephan JL; Fourquet B; Valteau-Couanet D; Bergeron C; Philip T; Carrie C
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1424-31. PubMed ID: 16427213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment with retinoic acid decreases bone mass in rats.
    Hotchkiss CE; Latendresse J; Ferguson SA
    Comp Med; 2006 Dec; 56(6):502-11. PubMed ID: 17219781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
    Yanovski JA; Rose SR; Municchi G; Pescovitz OH; Hill SC; Cassorla FG; Cutler GB
    N Engl J Med; 2003 Mar; 348(10):908-17. PubMed ID: 12621135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term complications in survivors of advanced stage neuroblastoma.
    Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
    Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.